Understanding sleep medication dependence, the effects of sleeping pills, signs of sleeping pill addiction, and how to find help for sleeping pill addiction at Phuket Island Rehab.
Clinically reviewed by Dr. Ponlawat Pitsuwan, Physician and Addiction Medicine Specialist, Phuket Island Rehab.
Sleeping pills include prescription sleep medication such as zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata), benzodiazepines such as temazepam and triazolam, and over-the-counter sleep aids built around diphenhydramine, doxylamine, or melatonin. Take sleeping pills every night for more than a few weeks and physical dependence develops; a smaller subset of patients develop the full behavioural pattern of sleeping pill addiction, including dose escalation, loss of control, and continued use despite harm. Sleeping pill abuse can lead to addiction, overdose, and dangerous interactions with alcohol. At Phuket Island Rehab, our medical detox supports patients ready to stop taking sleeping pills and rebuild sleep without medication.
What are sleeping pills?
The term sleeping pill covers several different classes of sleep medication. Prescription sleeping pills include the z-drugs zolpidem (Ambien), eszopiclone (Lunesta), and zaleplon (Sonata); benzodiazepines licensed for insomnia such as temazepam (Restoril) and triazolam (Halcion); sedating antidepressants such as trazodone and doxepin used off-label; melatonin receptor agonists such as ramelteon; and the dual orexin receptor antagonists such as suvorexant. Over-the-counter sleep aids are typically built around the sedating antihistamines diphenhydramine (Benadryl, ZzzQuil, Unisom SleepGels) and doxylamine (Unisom SleepTabs); melatonin is sold over the counter in many countries as a supplement. Sleeping pills are central to how primary care and emergency departments manage insomnia, but the long-term picture is more complicated than the prescription pad suggests.
Use of sleeping pills has risen sharply over the past two decades. National survey data from the Centers for Disease Control and Prevention show that around 8 to 10 percent of adults use prescription sleeping pills, with over-the-counter use higher still. Most people who take sleeping pills use them appropriately for short-term insomnia, but a meaningful minority develop a problem: tolerance, dose escalation, dependence, withdrawal, and in some cases the full behavioural pattern of sleeping pill addiction and abuse. Long-term use of sleeping pills, particularly the z-drugs and benzodiazepines, is associated with falls, cognitive impairment, dementia in older adults, and an increased risk of motor vehicle crashes the morning after dosing.
How a given sleeping pill behaves in the body depends on its drug class. Z-drugs and benzodiazepines act on the GABA-A receptor and produce sedation, anxiolysis, and a withdrawal syndrome that can include seizure. Sedating antihistamines act at histamine and acetylcholine receptors in the brain and produce sedation along with dry mouth, blurred vision, urinary retention, and an anticholinergic burden that raises dementia risk in older adults. Melatonin agonists work on the body’s circadian system; suvorexant blocks the wake-promoting orexin system. The clinical and addiction-related risks differ substantially between classes, but the behavioural pattern of taking sleeping pills nightly for years and being unable to stop is recognisable across all of them.
Sleep disorders are common, and trouble sleeping affects roughly one in three adults at some point. Insomnia and other sleep disorders, sleep problems including delayed sleep phase syndrome, restless legs, and sleep apnea, and stress (biology) responses that disrupt the body’s clock all drive patients to sleeping pills as a first solution. Sleep disorders are sometimes the result of an underlying medical condition or psychological factor, and stress management, anxiety treatment, and proper diagnosis matter at least as much as the choice of medication. Types of sleeping pills patients use include the nonbenzodiazepine z-drugs (zolpidem, zopiclone, eszopiclone, zaleplon), benzodiazepine sleeping pills like Ambien-class drugs and temazepam, sedating antidepressants such as trazodone, sedating antihistamines, melatonin, and orexin antagonists. Most of these sleeping pills can cause dependence with regular use.
The sedative effects of sleeping pills explain both the therapeutic benefit and the addiction risk. Help you fall asleep is the intended action; help you stay asleep through the night is the secondary benefit for long-acting agents. Pills with alcohol or sleeping pills like Ambien with alcohol produce dangerous deep sedation and are the leading driver of sleeping pill-related emergency department visits and overdose. Patients who abuse sleeping pills typically combine them with alcohol or take higher doses than prescribed to deepen the effect. Side effects of sleeping pills include sleep-walking and parasomnia, complex behaviours during partial wakefulness (driving, eating, sending messages with no memory the next day), severe withdrawal symptoms after stopping, and addiction to sleeping pills in the formal DSM-5 sense.
Patients addicted to sleeping pills, who experience withdrawal symptoms when they try to stop, who have a clear sleeping pill dependence and addiction, and who keep using the medication despite consequences, need a structured treatment program rather than another script. Stress, anxiety, and a worry that they will never sleep again often drive the use pattern. Information from credible sources, including SAMHSA and the National Institute on Drug Abuse, is the starting point. Try to stop taking sleeping pills without medical supervision rarely works in this group; the right level of care for taking the pills daily for years is usually a structured residential program followed by outpatient cognitive behavioural therapy for insomnia. Using the medication appropriately means time-limited, supervised, and paired with sleep hygiene work.
Use sleeping pills nightly for months and dependency develops. Drowsiness the next day, dependency on sleeping pills, and a felt inability to sleep without medication are the classic clinical picture. A healthcare provider should be the first stop when patients want to stop taking sleeping pills or recognise their dependency and abuse pattern. Sedative-hypnotics including the z drugs and benzodiazepines all carry this risk. Sleeping pills can lead to falls, hallucinations at higher doses, and benzodiazepine withdrawal syndrome on stopping. The dangers of sleeping pill addiction extend beyond the pill itself: drug and alcohol use frequently coexist, support groups such as twelve-step or SMART Recovery can help in the post-detox phase, and people who want to stop need a real medication to help bridge the worst of the rebound. Misusing sleeping in a way that is not prescribed, taking a higher dose than prescribed by a doctor, or stockpiling pills from multiple prescribers are the patterns that warrant getting help.
Withdrawal from sleeping pills can be severe. Sleeping pill withdrawal symptoms include severe rebound insomnia, panic attack, hallucinations, anxiety, drowsiness paradoxically, irritability, and benzodiazepine withdrawal syndrome with seizure risk in heavy long-term users. Side effects of sleeping pill use include impaired memory and cognition, falls (risk of falling rises with age), motor vehicle accidents, and complex behaviours during partial wakefulness. Effects of sleeping pill use on sleep quality are paradoxical: many long-term users report poor sleep quality despite eight hours of unconsciousness because the pills suppress deep slow-wave and REM sleep. Type of sleeping pill matters: z drugs, benzodiazepines, antidepressants, antihistamines, and orexin antagonists each produce different patterns of dependence, withdrawal, and overdose risk. Natural sleep without medication is the eventual goal, supported by natural sleep aids such as melatonin in physiological doses, sleep hygiene, and stimulus control.
Talk through your options with your doctor before stopping. Patients dependent on benzodiazepines or z-drugs should not stop abruptly. Health conditions including major depressive disorder, untreated anxiety, alcohol use disorder, alcohol withdrawal syndrome, post-traumatic stress disorder, and panic disorder are common in this admission group; treating mental health, treating these conditions in parallel with the taper improves sleep quality far more than any change in the medication. Help them sleep without the need for a nightly pill is the long-term goal. Taking sleep aids only short-term, paired with cognitive behavioural therapy for insomnia, is the only sustainable plan for chronic insomnia. Coping skills work, relaxation (psychology) techniques, and stress management address the underlying drivers that the pill has been masking. For patients with concurrent opioid use disorder, methadone or buprenorphine treatment is often needed before a sleeping pill taper can succeed, particularly when heroin or other opioids have been part of the polydrug picture. Improve sleep is the project; overcome sleeping pill dependence is one component of it.
How sleeping pills work
Z-drugs and benzodiazepines both target the GABA-A receptor, the same receptor system that mediates the effects of alcohol on sedation. Z-drugs bind preferentially to the alpha-1 subunit of the receptor, which is supposed to produce more selective sedation with less anxiolysis, less muscle relaxation, and less abuse potential than older benzodiazepines. In practice, the abuse potential of z-drugs has turned out to be higher than originally claimed, and zolpidem specifically has driven a large share of sleeping pill misuse referrals worldwide. Take sleeping pills like these every night for several weeks and the receptors in the brain downregulate, producing tolerance and dependence.
Sedating antihistamines such as diphenhydramine and doxylamine block central histamine H1 receptors, producing sedation, and also block muscarinic acetylcholine receptors, producing the anticholinergic side effects: dry mouth, urinary retention, blurred vision, constipation, and confusion. Tolerance to the sedative effect develops quickly, often within a week, which is one reason patients escalate the dose. The anticholinergic effects do not tolerate as quickly and accumulate, particularly in older patients.
Drug interactions matter for every sleeping pill class. Combining a sleeping pill with alcohol, opioids, gabapentinoids, or other sedating medication compounds central nervous system depression. Sleeping pill overdose alone is rarely fatal in adults; sleeping pill overdose in combination with alcohol or opioids is a leading driver of overdose deaths in older adults and a common factor in suicide attempts. Patients on a sleep medication should treat any sedating drug, prescribed or otherwise, as a potentially dangerous combination.
Which sleeping pill is dangerous?
Patients searching for which sleeping pill is dangerous are usually looking for a single safe option, and there is no completely safe long-term sleeping pill in the way they want there to be. The most dangerous prescription sleeping pills, in terms of addiction risk, are the short-acting benzodiazepines licensed for insomnia: triazolam (Halcion) and to a lesser extent temazepam (Restoril). Triazolam in particular produces a high rate of dependence and a difficult withdrawal because of its short half-life. The z-drugs zolpidem, eszopiclone, and zaleplon were marketed as safer alternatives to benzodiazepines, but their abuse potential is now well documented and includes amnesia, parasomnia behaviours, and a withdrawal syndrome similar to benzodiazepine withdrawal.
In overdose risk, the most dangerous sleeping pills are those that combine readily with alcohol or other sedatives. Most overdose deaths involving sleeping pills involve a polysubstance pattern rather than a sleeping pill alone. Over-the-counter sleep aids based on diphenhydramine carry a different and underappreciated profile of harm: cardiac toxicity at high doses, severe anticholinergic toxicity, and a clear association with dementia risk when taken for years. Patients who take sleeping pills every night for decades are at higher long-term cognitive risk than they are at acute overdose risk.
Top 10 sleeping pills patients ask about
The top 10 sleeping pills patients ask about in our clinic, in rough order of how often they come up, are zolpidem (Ambien), trazodone (used off-label), temazepam (Restoril), eszopiclone (Lunesta), zaleplon (Sonata), triazolam (Halcion), diphenhydramine (Benadryl, ZzzQuil), doxylamine (Unisom), melatonin, and quetiapine (used off-label at low doses). Each of these has a different mechanism, half-life, dependence profile, and place in clinical practice. None is a sustainable long-term sleep solution for chronic insomnia.
Of those, zolpidem and temazepam are the most common drivers of sleeping pill addiction referrals to our service. Trazodone is widely prescribed but produces a different pattern, more often a dependence pattern than the classical sleeping pill addiction picture. Diphenhydramine and doxylamine drive a larger population of long-term over-the-counter sleeping pill users who never see formal addiction services but are dependent in every meaningful sense. Quetiapine at low doses for sleep is increasingly common and carries its own metabolic side effects and dependence risk.
Sleeping pill abuse and addiction
Sleeping pill abuse, in the clinical sense, is repeated use that has begun to cause harm regardless of frequency or dose. Sleeping pill addiction and abuse is the formal pattern recognised in the Diagnostic and Statistical Manual of Mental Disorders, fifth edition, under sedative, hypnotic, or anxiolytic use disorder. Eleven criteria define the pattern: taking more than intended, repeated unsuccessful attempts to cut down, large amounts of time obtaining or recovering, craving, failure to meet obligations, continued use despite problems, hazardous use, continued use despite harm, tolerance, withdrawal, and giving up activities. Two to three criteria define a mild disorder; six or more is severe.
Three patterns drive sleeping pill misuse in practice. The first is iatrogenic dependence: a patient prescribed a sleep medication for a few weeks who simply never stopped, who quietly escalated the dose over months, and who now cannot fall asleep without the pill. The second is intentional polydrug use, where a sleeping pill is added to alcohol, benzodiazepines, opioids, or stimulants to produce a particular state. The third is the over-the-counter pattern: a patient relying on diphenhydramine or doxylamine for years, taking double or triple the labelled dose to maintain effect, frequently combined with alcohol. All three lead to addiction in the behavioural sense, even when none of the underlying drugs is a controlled substance.
Signs of sleeping pill addiction
Signs of sleeping pill addiction include taking sleeping pills more often or at higher doses than prescribed, running out of medication early, taking sleeping pills earlier in the evening to chase the same effect, doctor-shopping for additional prescriptions, hiding the level of use, persistent daytime sedation, falls, memory complaints, sleep that remains poor or has worsened despite escalating doses, and intense anxiety at bedtime when the pill is not available. Some patients describe a fear of sleeping without the pill that is itself a symptom of dependence. Effects of sleeping pills that persist into the next day, including hangover sedation and impaired driving, are also a warning sign that the dose or the choice of medication is wrong.
Sleeping pill abuse and addiction can lead to addiction patterns that look like other substance use disorders: cravings, behavioural reorganisation around the next dose, social withdrawal, and continued use despite mounting consequences. The signs and symptoms of sleeping pill addiction are not always dramatic, which is one reason the condition is often missed in primary care.
Sleeping pill withdrawal
Withdrawal symptoms after stopping a z-drug or benzodiazepine sleeping pill include rebound insomnia, anxiety, irritability, tremor, sweating, palpitations, nausea, perceptual disturbance, and in severe cases seizure. The pattern resembles benzodiazepine withdrawal and can be life-threatening if a patient stops abruptly after long-term use. Stop taking sleeping pills suddenly is not a safe plan for any patient who has used them nightly for more than a few weeks. Stop taking the medication on a structured taper, supervised by a clinician, is the safer route.
Symptoms typically begin within 24 hours of the last dose of a short-acting sleeping pill such as zolpidem, peak at three to five days, and resolve over one to two weeks for the acute phase. A subacute phase of persistent rebound insomnia, anxiety, and sleep disturbances continues through the rest of the first month. A subset develop a longer post-acute pattern with persistent sleep disruption and anxiety for several months, particularly if the original insomnia was never addressed behaviourally.
| Phase | Timing after last dose | Typical features |
|---|---|---|
| Acute physical | Day 1 to day 14 | Severe rebound insomnia, anxiety, tremor, sweating, palpitations, nausea, perceptual changes, risk of seizure |
| Subacute | Week 2 to week 6 | Persistent rebound insomnia, anxiety, low mood, sleep fragmentation, cravings |
| Post-acute | Month 2 to month 6+ | Persistent sleep disturbances, anxiety, vulnerability to relapse and to alcohol misuse |
Sleeping pill overdose
Sleeping pill overdose alone is rarely fatal in adults for the z-drugs, benzodiazepines licensed for insomnia, and sedating antihistamines, although serious overdoses do occur. Most fatal overdoses involving sleeping pills involve combination with alcohol, opioids, gabapentinoids, or another sedative. Sedating antihistamines in massive overdose can cause cardiac arrhythmia and seizure. The presence of a sleep medication in a polysubstance overdose is a frequent finding in coroner reports.
Older adults face additional acute risks: falls, hip fractures, motor vehicle crashes, and confusion or delirium. Long-term sleep medication use in older adults is associated with increased dementia risk and is listed on the Beers Criteria as potentially inappropriate. Sleeping pills should generally be avoided as a first-line treatment for insomnia in patients over 65.
Effects of sleeping pills over the long term
The effects of sleeping pills used short term are the ones the prescription is written for: faster sleep onset, fewer awakenings, more total sleep. The effects of sleeping pills used long term are different. Tolerance develops, the sedative effect wears off or requires higher doses, and rebound insomnia consolidates the use pattern: patients become afraid to stop because they remember how bad the unmedicated nights were. Long-term use is associated with cognitive impairment, falls, motor vehicle crash risk, and in observational studies an increased risk of dementia in older adults. Sleep architecture itself changes: many sleeping pills suppress deep slow-wave sleep and REM sleep, which is one reason chronic users often report unrefreshing sleep despite eight hours of unconsciousness.
The clinical recommendation across most national bodies, including the American Academy of Sleep Medicine and the National Health Service, is that sleeping pills should be reserved for short-term use, typically two to four weeks, and that chronic insomnia should be managed primarily with cognitive behavioural therapy for insomnia, sometimes called CBT-I, which has stronger evidence than any medication. In practice, prescription sleeping pills are used for months to years in most patients who start them, and most patients never receive CBT-I.
Find help for sleeping pill addiction at Phuket Island Rehab
Patients arrive at our centre for sleeping pill addiction treatment in three broad situations. Some have taken a sleep medication every night for years, want to stop, and have failed multiple outpatient taper attempts. Some are using sleeping pills alongside alcohol, benzodiazepines, or opioids and need a coordinated drug detoxification that addresses all substances at once. Some are using over-the-counter sleeping pills at escalating doses and have started to experience hangover sedation, falls, or anticholinergic side effects that they cannot ignore. Find help for sleeping pill addiction begins with a full clinical assessment of which pattern applies.
Help for sleeping pill addiction at our centre combines medical detox, behavioural treatment of the underlying insomnia, and management of any co-occurring alcohol use disorder, anxiety, or depression. Addiction treatment options begin with a structured medical taper. For a z-drug or benzodiazepine, daily dose reductions of 10 to 25 percent every five to seven days are common; for over-the-counter antihistamine-based sleep aids, a similar percentage taper applies. The pace is set by symptoms, not a calendar. Adjuncts include clonidine for autonomic symptoms, careful sleep hygiene, and seizure precautions where needed.
Cognitive behavioural therapy for insomnia, the modality with the strongest evidence base for chronic insomnia, runs in parallel with the taper from day one. Patients work with our counsellors on sleep restriction, stimulus control, cognitive restructuring around sleep-related fears, and the behavioural patterns that have organised around the nightly pill. Where a primary anxiety disorder, depression, or alcohol use disorder is identified, we address that condition concurrently. Long-term recovery requires a treatment plan that addresses behaviour, mood, sleep, sobriety, and the underlying mental disorder when present, not just the pharmacology.
Why international clients come to Thailand
Patients from the United States, the United Kingdom, Australia, and Europe travel to Phuket Island Rehab for several reasons specific to sleep medication recovery. The first is full removal from the prescribing environment. A patient who has spent years collecting sleeping pill prescriptions from the same GP, in the same bedroom, alongside the same evening drinking, often needs geographic distance to make a real break. Thailand provides that without the cost or visibility of inpatient programmes at home.
The second is privacy. Many of our clients are professionals, executives, or public figures, and a domestic admission for sleep medication dependence would draw attention they cannot afford. Treatment in Phuket is discreet by default, and the climate, food, and pace of the island reduce the institutional feel that so many patients dread.
The third is cost. A month of structured residential care in Phuket, including medical detox, therapy, accommodation, food, and excursions, costs a fraction of the equivalent programme in the United States or the United Kingdom. For self-funded patients without insurance coverage for sleep medication dependence specifically, that difference often means being able to commit to a longer stay, which is the single strongest predictor of long-term outcome.
When use of sleeping pills has become more than prescribed
Many of the people who reach out to our team are not in obvious crisis. They are still functional, still showing up to work, still seeing the same prescriber. What has changed is that they no longer feel they are choosing the medication; the medication is choosing them. The pill comes out earlier in the evening. A bad night ends with a second dose at 3am. Drinking is heavier than it used to be, and sleep is worse than it has been in years despite higher and higher doses.
If that pattern is familiar, the question is no longer whether the sleeping pill is appropriate in the abstract. It is whether the current pattern is moving in the direction the patient wants their life to go. A conversation with an addiction specialist, a properly supervised taper, and time away from the bedroom and the drinking that have shaped the habit are reasonable next steps. Sleeping pills work for many patients short term. For others, they are a bridge, and bridges are designed to be crossed.
Summary
Sleeping pills are one of the most commonly prescribed classes of medication in primary care, and most patients who start them are still taking them months to years later. Sleeping pill addiction, sleeping pill abuse, dependence, and a real withdrawal syndrome all exist across z-drugs, benzodiazepines, and even over-the-counter sleep aids. The clinical task is not to decide whether the medication is good or bad, but to read the individual patient in front of you and to plan the next step, whether that is short-term continued use, a slow taper, a switch to behavioural treatment, or a residential detox away from the original prescribing environment.
As our physician Dr. Ponlawat Pitsuwan puts it, “The patients who do best when stopping a sleeping pill are the ones who treat the taper as the start of sleep work, not the end of medication. When non-pharmacological sleep restoration becomes the main project, the pill fades into the background where it belongs.”
Frequently asked questions
Are sleeping pills addictive?
Yes. Prescription sleeping pills including z-drugs (zolpidem, eszopiclone, zaleplon), benzodiazepines (temazepam, triazolam), and even sedating antihistamines in over-the-counter sleep aids produce physical dependence with nightly use beyond a few weeks. A smaller subset of users develop the full behavioural pattern of sleeping pill addiction: dose escalation, loss of control, craving, and continued use despite harm. Sleeping pill addiction and abuse is a recognised diagnosis in the DSM-5 under sedative, hypnotic, or anxiolytic use disorder.
Is doxylamine succinate addictive?
Doxylamine succinate, the sedating antihistamine in Unisom SleepTabs and many night-time cold formulations, is not a controlled substance and does not produce euphoria in the way benzodiazepines or opioids do. Physical dependence and a psychological dependence pattern do develop with nightly use over months to years. Tolerance to the sedative effect builds quickly, often within a week, which drives many users to escalate the dose. Whether doxylamine succinate is addictive depends on how addiction is defined: not in the controlled-substance sense, yes in the behavioural and clinical sense.
Can you overdose on sleeping pills?
Sleeping pill overdose with a prescription sleeping pill alone is rarely fatal in adults. The picture changes sharply when other central nervous system depressants are involved. Sleeping pill overdose in combination with alcohol, opioids, benzodiazepines, or other sedatives can cause profound respiratory depression and death. Massive overdose of sedating antihistamines such as diphenhydramine can cause cardiac arrhythmia and seizure independent of any combination. Patients on a sleeping pill should treat any sedating drug, prescribed or otherwise, as a potentially dangerous combination.
How long does it take to stop using sleeping pills?
Stop using sleeping pills safely takes weeks to months under medical supervision, depending on the drug, the dose, the duration of use, and the patient’s underlying insomnia. A z-drug or benzodiazepine taper typically runs four to twelve weeks. A taper from over-the-counter antihistamine-based sleep aids is often faster but still requires careful attention to rebound insomnia. The full recovery, including sleep restoration, anxiety management, and consolidation of cognitive behavioural therapy for insomnia, typically runs three to six months.
What can I take instead of sleeping pills?
The evidence-based alternative to long-term sleeping pill use for chronic insomnia is cognitive behavioural therapy for insomnia, sometimes called CBT-I, which has stronger evidence than any medication for chronic insomnia. Sleep hygiene measures, stimulus control, sleep restriction, cognitive restructuring around sleep-related fears, and treatment of underlying anxiety, depression, or alcohol use disorder are the components. Melatonin at appropriate doses may help with circadian-rhythm disorders but is not a substitute for behavioural treatment. For some patients, a short-term bridge with a non-addictive sedating medication may be useful during the taper.
Do I need residential treatment to come off sleeping pills?
Many stable patients with strong support can taper a sleeping pill in outpatient care under a knowledgeable prescriber. Residential treatment becomes the better option when previous outpatient attempts have stalled, when use of alcohol or other substances is part of the picture, when underlying anxiety or depression is unstable, when the home environment was where the original sleeping pill use developed, or when the patient has lost the felt distinction between sleeping with the pill and being unable to imagine life without it. The honest test is whether you can imagine yourself sleeping without the medication in the life you currently live.
Sources
Substance Abuse and Mental Health Services Administration. National helpline and treatment locator. samhsa.gov. SAMHSA resources on sedative use disorder, addiction treatment options, and the mental health services administration national helpline.
National Institute on Drug Abuse. Prescription CNS depressants research report. nida.nih.gov.
U.S. Food and Drug Administration. Drug safety communication on z-drugs including zolpidem, eszopiclone, and zaleplon. fda.gov.
American Academy of Sleep Medicine. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults. aasm.org.
National Health Service. Sleeping pills and minor tranquillisers. nhs.uk.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fifth edition, text revision. Sedative, hypnotic, or anxiolytic use disorder, criteria and severity ratings.
Lifeline Australia. National Alcohol and Other Drug Hotline. lifeline.org.au.
Related reading on this site
- Which sleeping pill is dangerous?
- Top 10 sleeping pills
- Is doxylamine succinate addictive?
- Ambien addiction
- Trazodone addiction
- Ativan addiction
- Barbiturate addiction
- Anxiety treatment
- Medical detox at Phuket Island Rehab
- Our rehab programme
sleeping pill, sleeping pills, sleep medication, sleep aid, hypnotic, sedative, sedative-hypnotic, prescription sleeping pills, over-the-counter sleep aid, over-the-counter drug, z-drug, zolpidem, Ambien, eszopiclone, Lunesta, zaleplon, Sonata, temazepam, Restoril, triazolam, Halcion, benzodiazepine, diazepam, lorazepam, alprazolam, clonazepam, diphenhydramine, doxylamine, doxylamine succinate, melatonin, ramelteon, suvorexant, trazodone, doxepin, quetiapine, antidepressant, GABA, GABA-A receptor, receptors in the brain, histamine H1 receptor, muscarinic acetylcholine receptor, anticholinergic, anticholinergic burden, alcohol (drug), alcohol use disorder, polysubstance use, opioid, insomnia, primary insomnia, sleep disorder, sleep, sleep architecture, rebound insomnia, parasomnia, fall asleep, addiction, drug addiction, sedative use disorder, sleeping pill addiction, sleeping pill abuse, substance dependence, physical dependence, psychological dependence, substance abuse, substance use, substance use disorder, drug withdrawal, drug detoxification, drug rehabilitation, drug abuse, drug overdose, dose (biochemistry), tolerance, off-label use, controlled substance, Schedule IV, status epilepticus, seizure, ataxia, hypotension, respiratory depression, falls, dementia, cognitive impairment, motor vehicle crash, Beers Criteria, hangover sedation, anxiety, generalised anxiety disorder, post-traumatic stress disorder, mood disorder, depression, mental disorder, mental health, dual diagnosis, behavior, signs and symptoms, side effect, health, health professional, therapy, psychotherapy, cognitive behavioral therapy, CBT-I, sleep hygiene, stimulus control, sleep restriction, relapse, sobriety, risk, DSM-5, U.S. Food and Drug Administration, FDA, SAMHSA, National Institute on Drug Abuse, American Academy of Sleep Medicine, National Health Service, Lifeline Australia, Phuket Island Rehab.